-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Caribou Biosciences, Lowers Price Target to $5

Benzinga·08/14/2026 18:25:04
Listen to the news
B of A Securities analyst Alec Stranahan maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price target from $6 to $5.